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ABSTRACT 
Rationale and objectives: Suffering through infective endocarditis can drastically alter a 
person’s physical appearance, and body image related concerns have been reported by 
patients. The extent and severity of the phenomenon has not previously been explored, as no 
quantitative measure has been validated in this patient population. The purpose of this study 
was thus to assess the validity, reliability and responsiveness of the Danish Body Image 
Quality of Life Inventory (BIQLI-DA) on patients treated for infective endocarditis.  
Methods: We evaluated the psychometric properties of the BIQLI-DA on data obtained in the 
CopenHeart IE trial, which is a randomized clinical trial evaluating the effects of 
comprehensive cardiac rehabilitation for patients treated for infective endocarditis. We 
administered the BIQLI-DA as part of data collection at baseline and six months. We 
examined the psychometric properties through correlations to other measures, including Body 
Mass Index (BMI), Medical Outcome Short Form 36 (SF-36) and Hospital Anxiety and 
Depression Scale (HADS). In addition we examined internal consistency on item and scale 
level and performed ANOVA group by time interaction to test for responsiveness. 
Results and study limitation: Participants were seventy patients with a mean age of 58 years 
and of which 83% were men. Results indicated convergent construct validity by confirming 
hypothesized associations to potentially related constructs. The BIQLI-DA was found to be 
highly internally consistent with a Cronbach’s alpha of 0.96. Instrument responsiveness was 
indicated by a significant group-by-time interaction. Support for the validity of the BIQLI-DA 
might have been strengthened by a larger sample with more women. A more optimal design 
for testing responsiveness would possibly have allowed for clearer conclusions.   
Conclusions: The BIQLI-DA may be applicable in health care research as it seems to be valid, 
reliable and responsive, however evidence should be strengthened through further exploration 
of instrument performance, particularly regarding responsiveness. 
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INTRODUCTION 
Infective Endocarditis (IE) is an infection of the heart valves and it is among the most serious 
infectious diseases in the western world (1). Bacteria may invade and destroy the tissue, and 
vegetations can dislodge into circulation, causing harmful and potentially deadly 
complications. Treatment requires lengthy hospitalization, high dosage antibiotics and 
possible valve replacement surgery (1,2).  
The pathophysiology and treatment of the disease can drastically alter a person’s physical 
appearance during the course of the illness (3). The infection itself and the antibiotic treatment 
will often affect the patient’s appetite and gastrointestinal function and, as a result, 
considerable weight loss is common (4). Long term hospitalization, entailing general 
inactivity and bed rest may also cause loss of muscle mass (5) and surgical interventions 
related to either cardiac device or heart valve surgery will leave permanent scars on more than 
50% of patients (6).  
Negative body image has been reported in a number of cardiac populations such as patients 
with congenital heart disease (7,8), patients with implanted cardiac devices (9,10) and heart 
transplant candidates (11). Qualitative studies have identified concerns about bodily 
appearance and sensations in patients with IE (3,12). Patients reported an increased level of 
attention to body-signals and concerns about interpretation of symptoms, which made them 
fearful of recurrence (3,12). Furthermore, some patients described their body as being 
disfigured and emphasized concerns about visible traces, particularly scars and weight loss 
which kept reminding them of their illness (3,12). Assessment of body image and its impact 
on patients’ lives is important to appraise the extent and magnitude of these problems and to 
identify potential targets for intervention. For this a valid and reliable instrument is needed. 
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The Body Image Quality of Life Inventory (BIQLI) was developed by the American 
psychologist Thomas F. Cash in 2002. It is a 19 item self-report measure that quantifies the 
influence of the subjects’ body image experiences on various relevant facets of psychosocial 
functioning and wellbeing in everyday life. It uses a 7 point response format ranging from 
very negative (-3) to very positive (+3) effects of body image on 19 life domains (13). A 
composite negative score may thus indicate a negative influence of an individual’s body 
image on their quality of life while a positive score may indicate a positive influence. The 
inventory seemed a good fit for capturing illness related body image concerns, as the focus is 
on body image as a situational variable trait and of the influence of one’s body image on ones 
quality of life. This makes the inventory especially relevant for measuring body image in 
relation to a broad range of health conditions and disciplines and also, possibly, to measure 
sensitivity to change due to health care interventions  
The inventory was initially validated on female college students and high internal consistency 
(Cronbach’s alpha = 0.95), good item-total correlations (0.45-0.86) and stability over a 2-3 
week period (test-retest reliability = 0.79) were demonstrated (13). Moreover, convergent 
construct validity was shown by significant relationships with different standardized measures 
of body image (13). The instrument has subsequently been validated for utilization with both 
genders (14) and on a wider range of age groups (15). The instrument has been validated in a 
Spanish version (16) and a Brazilian Portuguese version (17) and has been used in different 
patient populations (17-23). However, it is not known whether the instrument is valid and 
reliable for use in IE patients. Therefore, the aims of this study are to test the Danish version 
of the Body Image Quality of Life (BIQLI-DA) on a sample of patients treated for IE in order 
to assess: (i) the reliability and validity of the instrument in measuring body image related 
concerns and (ii) evaluate the instrument’s responsiveness to a healthcare intervention.  
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METHODS 
In order to develop a Danish version of the BIQLI-DA, the authors of this article undertook 
the rigorous process of systematic translation of the original English version and initial 
validation of the adapted Danish version (BIQLI-DA) on a sample of college students. Results 
showed support for the semantic equivalence, internal consistency reliability and convergent 
construct validity of the measure. Results also revealed some concerns about face validity and 
this issue is discussed (24). 
Design and study population 
We evaluated the psychometric properties of the BIQLI-DA on data obtained in the 
CopenHeart IE trial, which is a randomized clinical trial evaluating the effects of 
comprehensive cardiac rehabilitation for patients treated for IE (25). Exercise training and 
interventions to improve body awareness have been suggested as interventions to improve 
adverse outcomes related to body image (26,27).  The trial intervention consists of a 12 week 
individualized training program and a total of five psycho-educational consultations carried 
out by experienced cardiac care nurses. Trial inclusion commenced in December 2011 and is 
still on-going. Data collection for the validation study on a subset of participants was 
completed in January 2015. Recruitment was restricted by the number of eligible participants 
available for trial participation. The sample initially consisted of 77 patients treated for IE. 
Three withdrew before initial data collection and an additional four did not complete baseline 
questionnaires, leaving a sample of 70 respondents (58 men and 12 women) with a mean age 
of 58 at baseline (BL). At six months (T6) one additional participant had withdrawn, nine did 
not complete T6 questionnaire and 12 had not yet reached the six month time point, leaving a 
sample of 48 respondents (42 men and six women) at six months. Selected demographic and 
clinical characteristics of baseline participants are presented in Table 1.  
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Data-collection 
The BIQLI-DA was included as part of the internet based questionnaire packages used in the 
CopenHeart IE trial. Paper and pencil administration was possible on request by participants. 
The BIQLI-DA was included at baseline and at six months and was completed by participants 
along with a number of other instruments of which two were used in the present study (see 
section on measures). Additional questions about demographic characteristics were included 
at baseline. All participants were informed about study purpose, procedures, voluntary 
participation and anonymity, verbally and in writing.  
Psychometric properties 
The quality of an instrument is typically assessed by psychometric testing relating to its 
validity and the reliability (28-31). Validity refers to the extent to which an instrument and/or 
its subscales reflect the intended construct or phenomenon (28). We assessed the validity of 
the BIQLI-DA by examining hypothesized correlations to other measures. Reliability refers to 
the consistency, stability and dependability with which an instrument measures the construct 
or phenomenon it aims for (29). We assessed the reliability of the BIQLI-DA on this sample 
by examining its internal consistency on scale and item level. We also assessed the 
responsiveness of the BQLI-DA, which refers to the instrument’s ability to detect an 
important change over time in the construct to be measured (32). Assessing the 
responsiveness of the BIQLI-DA allows us to determine its appropriateness as an outcome 
parameter in clinical trials. 
Hypotheses 
Based on prior research findings, the following hypotheses were generated and tested in order 
to obtain evidence that supports validity in relationship to other variables.  
Hypothesis 1: Body image quality of life is negatively associated with BMI in women. This 
relationship has been shown in other studies in younger women (13,14,16) .  
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Hypothesis 2: Body image quality of life is positively associated with increasing age. A more 
positive body image quality of life has been shown to be related to increasing age (15).   
Hypothesis 3: Body image quality of life is negatively associated with estimated weight loss. 
Qualitative studies find that patients have concerns about bodily changes that commonly 
occur during illness, such as weight loss (3,12). 
Hypothesis 4: Body image quality of life is positively associated with self-rated physical 
health as measured by the Physical Component Score (PCS) of the SF-36, where higher 
scores indicate better perceived physical health. Qualitative findings reveal that patients have 
an increased awareness of their bodies and physical symptoms after illness (3,12).  
Hypothesis 5: Body image quality of life is positively associated with self-rated mental health 
as measured by the Mental Component Score (MCS) of the SF-36, where higher scores 
indicate better perceived mental health. This association was demonstrated in the initial 
validation study of the Danish version of the BIQLI-DA (24). 
Hypothesis 6: Body image quality of life is negatively associated with anxiety as measured by 
the Hospital Anxiety and Depression scale (HADS), with higher scores indicating higher 
anxiety levels. This association has been found in the initial validation study of the BIQLI-
DA (24). 
Hypothesis 7: Body image quality of life is negatively associated with indicators of 
depression as measured by the HADS, with higher scores indicating signs of depression. This 
relationship was also shown in the initial BIQLI-DA validation study (24). 
Due to the exploratory nature of this study, we chose to examine correlations on men and 
women separately, as well as in the total sample. We expected weak to moderate correlations 
as we were measuring potentially related but different concepts. We used Cohen’s proposition 
for cut-offs for correlation coefficients: > 0.1 = small; >0.3 = moderate; > 0.5 = strong (33). 
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Measures 
In order to test the hypotheses, data from other measures were collected. The choice of 
measures was restricted by their availability in Danish. 
Body Mass Index (BMI) (34) is a measure of an individual’s weight, divided by the square of 
their height (kg/m2). A high body mass can be an indicator of high body fatness. It is 
commonly used to assess how much an individual’s body weight deviate’s from what is 
recommended for his or her height.  
The Medical Outcome Scale Short Form 36 (SF-36) is a measure of self-rated health. It uses 
36 items to measure eight components: physical functioning (PF), role-physical (RP), bodily 
pain (BP), general health (GH), vitality (VT), social functioning (SF), role-emotional (RE) 
and mental health (MH). Scores are calculated for each component and aggregated into two 
summary scores, a mental component score (MCS) and a physical component score (PCS). 
Factor analysis studies have confirmed physical and mental health factors that account for 
80% to 85% of the reliable variance in the eight scales (35). Scores range from 0 to 100 with 
higher scores indicating better perceived health (36,37). With rare exceptions, published 
reliability statistics have exceeded the minimum standard of Cronbach's alpha of 0.70 
recommended for measures used in group comparisons in more than 25 studies (38) and most 
have exceeded 0.80 (39-41). Reliability estimates for physical and mental summary scores 
usually exceed 0.90 (42). The SF-36 health survey has been validated in Danish (43,44). 
Hospital Anxiety and Depression Scale (HADS) is a 14-item questionnaire that assesses levels 
of depression and anxiety in medically ill patients. The scale offers two scores, HADS-A and 
HADS-D and consists of seven questions to assess anxiety and seven questions to assess 
depression (45). For each of the questions the respondent chooses from four responses 
to indicate the frequency/extent to which each applies for the last week. The HADS has been 
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demonstrated to be valid and internally consistent, with a mean Cronbach’s alpha of 0.83 and 
0.82 for the HADS-A and HADS-D respectively (46). To our knowledge validation studies on 
the HADS in Danish have not been published.  
Statistical analysis 
Statistical analyses were performed using the IBM SPSS® 20.0 software package. Prior to 
analysis, data were examined for missing data, variables’ distribution and relationships in 
order to choose the appropriate statistical models for analyses. Hypothesized correlations 
were investigated using Spearmann’s rank order correlation coefficient as data were not 
normally distributed. Descriptive statistics were performed to quantify demographic 
characteristics. Internal consistency of measures was determined using Cronbach’s alpha. In 
order to test instrument responsiveness, we performed ANOVA group-by-time interaction as 
a way of comparing change in body image as measured by BIQLI-DA over time between the 
intervention and the control group of the CopenHeart IE trial. Except for the ANOVA, all 
analyses were on baseline data.  For relevant analyses, significance level was set at 0.05. 
 
RESULTS 
Validity 
Convergent construct validity was examined through correlations with the previously 
mentioned variables. Results are shown in Table 2. All of our hypotheses of weak to moderate 
correlations between the BIQLI-DA and related traits were confirmed. In the gender-specific 
analyses, some correlations were quite weak or non-existent. This was especially the case in 
self-rated physical and mental health, where no association is found in women for physical 
health and none for men in mental health. For the remainder of the variables, the magnitude of 
the associations in women compared to men was noticeably higher and in several cases 
associations were strong. 
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Reliability  
Internal consistency reliability determined by Cronbach’s alpha of the BIQLI-DA was 0.96 
for this sample at baseline, demonstrating excellent internal consistency between items, 
exceeding the recommended minimum of 0.70 for a respectable alpha (28).  Corrected item-
total correlations ranged from 0.61 to 0.86 with no items demonstrating poor correlation or an 
increase in Cronbach’s alpha if deleted, as shown in Table 3. 
Responsiveness 
Figure 1 shows the baseline and T6 BIQLI-DA scores for the intervention and control groups 
in the CopenHeart IE trial. The analysis was performed on the 48 participants who had 
completed the BIQLI-DA at both baseline and T6. Means at baseline were 0.7 and 1.5 for the 
intervention and control group respectively and means at T6 were 0.8 and 1.1 respectively. 
We found a significant group-by-time interaction between the two groups; those who received 
the CopenHeart IE intervention and those who did not (p = 0.03), indicating a significant 
difference in body image scores between groups over time and thus suggesting the 
responsiveness of the BIQLI-DA. 
 
DISCUSSION 
This study examined the psychometric properties of the Danish Body Image Quality of Life 
Inventory (BIQLI-DA) on a sample of patients treated for infective endocarditis in order to 
evaluate its applicability in health care research.  
Validity based on relationships to other variables was demonstrated by confirmation of the 
seven hypotheses. The correlations were generally weak, especially for men, but this was in 
line with the expectations. Results demonstrated an association between body image quality 
of life and BMI, particularly in women, which is consistent with previous findings (14,16,17). 
Based on patient reports in qualitative studies, we also tested and confirmed a hypothesized 
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association between body image quality of life and weight loss. This may seem to contradict 
the BMI association, however, in this population patients report that weight loss is perceived 
as a negative consequence of long standing disease which has altered their appearance 
negatively (12). Hence the weight loss related to the deleterious effects of disease and 
treatment on the body seems to affect a person’s body image and this association, as well as 
the known association with overweight, can both be detected in this sample. The relatively 
broad age range in our study allowed us to test the correlation between age and body image 
quality of life. Studies have shown that increasing age is correlated to higher BIQLI scores, 
particularly in men (15) and this association was confirmed in our study for men, as well as 
for women. The assumption that body image quality of life is related to self-rated mental 
health, anxiety and depression was confirmed in this sample mainly in women, but for 
depression also in men, thus supporting the validity of the BIQLI-DA. In our initial validation 
study we provided first time evidence of an association between the mentioned indicators of 
mental health and body image quality of life (24). This study confirms such relationships by 
demonstrating noticeable correlations, particularly in women, in this sample of patients 
treated for IE. The association to self-rated physical health, however, is quite weak and non-
existent for women. This was slightly surprising to us, as the qualitative findings had 
indicated that body image concerns in IE patients may be less linked to physical appearance 
and more to bodily sensations and functioning, which we presumed to be related to physical 
health. This association was not clear in our sample. The instrument shows excellent internal 
consistency and high corrected item-total correlations in this sample. These finding are 
similar to previous reports (13,14,16,17). We found a significant group-by-time interaction 
indicating differential change over time between groups, thus suggesting the responsiveness 
of the BIQLI-DA and its applicability in intervention studies. This way of testing 
responsiveness however is encumbered by possible misinterpretation as we cannot be sure the 
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change detected is an affirmation of sensitivity of the instrument and there are no prior studies 
supporting our findings.  
 
METHODOLOGICAL CONSIDERATIONS AND RESEARCH DIRECTIONS 
A process of systematic translation and validation preceded this study, ensuring instrument 
equivalence and initial evidence of instrument validity and reliability. Consistent with 
previous findings, the psychometric testing on patients treated for IE supports the conclusion 
that the BIQLI-DA is a valid and reliable measure however conclusions are restricted by 
sample size and characteristics, particularly the small proportion of women. The scant 
availability of valid measures in Danish limited our choice of methods. Access to other 
measures of body image and not merely related constructs, would have been optimal in 
providing evidence of convergent validity and would have enabled us to examine the 
magnitude and direction of change over time between measures of the same construct as a 
way of testing responsiveness. As we detected some issues with the face validity in the initial 
validation study, it might have been advantageous to do cognitive interviews in the IE sample, 
in order to assess comprehensibility in this population. The study might also have been 
strengthened by having been designed and performed independently of the CopenHeart IE 
clinical trial. Questionnaire administrations at baseline and six months were both quite 
extensive (215 and 260 items respectively) and the BIQLI-DA was placed last in both. This 
may have resulted in response fatigue and affected the accuracy of results.  
Further studies on larger samples are needed in order to explore the validity of the measure in 
patient populations  and also to explore whether an instrument including bodily sensations 
and functioning may be more suitable for capturing body image concerns in people who have 
suffered from IE or other acute or chronic illness. Lastly, additional testing on other patient 
populations is needed, to establish the applicability and appropriateness of the BIQLI-DA 
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both as a measure in descriptive studies, and also whether the instrument is sensitive to 
change due to health care interventions and can be used in randomized clinical trials.  
 
CONCLUSION 
Our results show support for the validity, reliability and responsiveness of the BIQLI-DA in 
patients treated for IE. However, based on the experiences of our initial validation study and 
methodological limitations of this study, we see that there might be an issue concerning 
certain aspects of validity. This issue should be explored further before the use of the BIQLI-
DA for interventional healthcare research can be fully supported. 
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Table 1. Demographic and clinical characteristics of participants 
 BL (n = 70) 
Male sex, n (%) 58 (82.9) 
Age in years, mean (±SD)/ range  58.0 (14.2) / 22 - 83  
Married/Domestic partner, n (%) 49 (70.0) 
Type of IE: 
 Left-sided (Native- or prosthetic heart valve, aortic-, mitral- 
or both), n (%) 
57 (81.4) 
 Cardiac device (PM1, ICD2, CRT-P or -D3), n (%) 10 (14.3) 
 Left-sided heart valve and cardiac device, n (%) 3 (4.3) 
Type of surgery: 
 Heart valve surgery, n (%) 
32 (45.7) 
 Device surgery, n (%) 9 (12.9) 
 Heart valve- and device surgery, n (%) 2 (2.9) 
 No surgery, n (%) 27 (38.6) 
Weight-loss in kilograms, mean (±SD)/ range 5.0 (5.0) / 0 - 18 
BMI in kg/m2, mean (±SD)/ range 25.9 (4.2) / 17.9 - 42.4 
Intervention group, n (%) (36) 51.4% 
Weight loss is a self-reported estimate by patients. 
PM1 = Pacemaker, ICD2 = Implantable Cardio Defibrillator, CRT-P or -D3 = Cardiac Resynchronization Therapy - Pacemaker 
or -Defibrillator 
 
Table 2. Correlation the BIQLI-DA and other measures 
Measures Spearman’s Correlation Coefficient 1 (r) 
Name (+ subscales) 
Total sample 
(N = 70) 
Men  
(N = 58) 
Women 
(N = 12) 
Body Mass Index (BMI) - 0.26* - 0.26* - 0.40 
Estimated weight loss # - 0.24 - 0.15 - 0.60 
Age 0.30* 0.30* 0.38 
Medical Outcome Short Form - 36 (SF-36)    
Physical Component Score (PCS) 0.14 0.18 0.06 
Mental Component Score (MCS) 0.12 0.04 0.49 
Hospital Anxiety and Depression Scale (HADS)    
HADS-A (Anxiety scale) - 0.20 - 0.15 - 0.56 
HADS-D (Depression scale) - 0.42** - 0.43** - 0.50 
1 Bivariate analyzes, # only on the 50 patients who had had weight loss 
* p < 0.05, ** p < 0.01. 
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Table 3. Reliability Statistics 
Item 
Corrected 
item-total 
Correlation 
Cronbach’s 
Alpha if item 
Deleted 
1. My basic feelings about myself – feelings of personal adequacy and 
self-worth. 
0.77 0.959 
2. My feelings about my adequacy as a man or woman - feelings of 
masculinity or femininity. 
0.72 0. 959 
3. My interactions with people of my own sex. 0.74 0. 959 
4. My interactions with people of the other sex. 0.80 0.958 
5. My experiences when I meet new people. 0.77 0. 959 
6. My experiences at work or at school. 0.70 0.960 
7. My relationships with friends. 0.74 0. 959 
8. My relationships with family members. 0.77 0. 959 
9. My day-to-day emotions. 0.86 0.957 
10. My satisfaction with my life in general. 0.81 0.958 
11. My feelings of acceptability as a sexual partner. 0.70 0.960 
12. My enjoyment of my sex life. 0.71 0. 960 
13. My ability to control what and how much I eat. 0.66 0. 960 
14. My ability to control my weight. 0.71 0. 960 
15. My activities for physical exercise. 0.68 0. 960 
16. My willingness to do things that might call attention to my 
appearance. 
0.61 0.961 
17. My daily “grooming” activities (i.e., getting dressed and physically 
ready for the day). 
0.67 0. 960 
18. How confident I feel in my everyday life. 0.81 0. 958 
19. How happy I feel in my everyday life. 0.83 0.958 
The Body Image Quality of Life Inventory is copyrighted by Thomas F. Cash, Ph.D.  Use of the assessment 
requires his permission (see www.body-images.com).  
 
Figure 1. ANOVA group-by-time interaction 
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